Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Menopause01:28

Menopause

3.4K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
3.4K
Bone Disorders01:29

Bone Disorders

5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

123
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
123
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

116
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
116
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

3.1K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.1K
Aging01:26

Aging

490
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
490

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Examining the status quo and related factors of clinical nurses' spare-time planning.

Frontiers in public health·2026
Same author

Comparing the Waterlow and Jackson/Cubbin pressure injury risk scales in intensive care units: A multi-centre study.

International wound journal·2026
Same author

The emerging role of T cells in depression.

Frontiers in psychiatry·2026
Same author

Hydroalcoholic gel of Angelica sinensis polysaccharides promotes wound healing by suppressing ferroptosis through PI3K/AKT/Nrf2 signaling pathway.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Same author

Deciphering the anticoccidial mechanism of Qinghao Changshan formula through network pharmacology and molecular docking.

Veterinary world·2025
Same author

Patient Referral and Pressure Injuries: A Systematic Review.

Nursing open·2025

Related Experiment Video

Updated: Dec 14, 2025

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
04:00

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles

Published on: July 26, 2024

1.0K

Menopause and frailty: a scoping review.

Haihui Ruan1, Junping Hu2, Jinzhu Zhao2

  • 1School of Nursing, Lanzhou University, Lanzhou, Gansu, China.

Menopause (New York, N.Y.)
|July 24, 2020
PubMed
Summary

Menopause is linked to frailty in women. Factors like early menopause, hysterectomy, and hormonal changes may increase frailty risk. Further research is needed to understand these connections.

More Related Videos

Frailty Assessment in an Aging Mouse Model
06:58

Frailty Assessment in an Aging Mouse Model

Published on: September 23, 2025

277
Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
05:53

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Published on: July 24, 2013

16.9K

Related Experiment Videos

Last Updated: Dec 14, 2025

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
04:00

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles

Published on: July 26, 2024

1.0K
Frailty Assessment in an Aging Mouse Model
06:58

Frailty Assessment in an Aging Mouse Model

Published on: September 23, 2025

277
Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
05:53

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Published on: July 24, 2013

16.9K

Area of Science:

  • Gerontology
  • Women's Health
  • Physiology

Background:

  • Frailty is a decline in physiological reserve, increasing vulnerability, with higher prevalence in women.
  • Menopause and related factors are potential contributors to frailty in women, but underlying mechanisms are unclear.

Purpose of the Study:

  • To explore the relationship between menopause and frailty in postmenopausal women.
  • To summarize data on menopausal age, duration, types, and associated hormonal and inflammatory markers of frailty.

Main Methods:

  • A comprehensive literature search was conducted across multiple databases up to April 2019.
  • Included studies were supplemented by reference, citation, and similar document searches.

Main Results:

  • 15 articles were included, showing frailty prevalence from 5.9% to 57.3% in postmenopausal women.
  • Early menopause, hysterectomy, low testosterone, and high C-reactive protein are associated with increased frailty risk.
  • Estrogen's role is unclear due to conflicting results; hormonal and inflammatory changes may mediate frailty.

Conclusions:

  • Menopause is associated with frailty in postmenopausal women.
  • Hormonal and inflammatory markers appear to play a role in frailty development.
  • More research is necessary to elucidate the physiological and etiological mechanisms linking menopause and frailty.